Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
72
Frequently Asked Questions
What is Market Cap of Lucid Diagnostics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Lucid Diagnostics Inc market cap is $111.73M.
What is the 52-week high for Lucid Diagnostics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lucid Diagnostics Inc 52 week high is $1.80 as of September 15, 2025.
What is the 52-week low for Lucid Diagnostics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lucid Diagnostics Inc 52 week low is $0.73 as of September 15, 2025.
What is Lucid Diagnostics Inc stock price today?
Lucid Diagnostics Inc stock price today is $1.06.
What was Lucid Diagnostics Inc stock price yesterday?
Lucid Diagnostics Inc stock price yesterday was $1.03.
What is the PE ratio of Lucid Diagnostics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Lucid Diagnostics Inc’s P/E ratio is -0.98.
What is the Price-to-Book ratio of Lucid Diagnostics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Lucid Diagnostics Inc P/B ratio is -2.2527.
What is the 50-day moving average of Lucid Diagnostics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Lucid Diagnostics Inc 50-day moving average is $1.10.
How many employess does Lucid Diagnostics Inc has?